Latency and tumorigenesis in Marek's disease

Area of Science:

• Virology
• Oncology
• Immunology

Background:

• Marek's disease (MD) is a complex viral disease caused by Marek's disease virus (MDV).
• Despite progress, critical aspects of MDV biology, including virus latency and host-virus interactions in lymphoma, are not fully understood.
• The unique environment of feather follicle epithelial cells supporting cytolytic infection alongside lymphoid cell latency remains unclear.

Purpose of the Study:

• To elucidate unknown features of Marek's disease (MD) and Marek's disease virus (MDV) biology.
• To identify key aspects of virus latency in lymphoid cells and virus-host interactions in MDV-induced lymphoma.
• To investigate the characteristics of latent infection, its distinction from the tumor phase, and its potential prerequisite role in MDV pathogenesis.

Main Methods:

• Analysis of viral gene functions in disease pathogenesis.
• Investigation of epigenetic regulation, including DNA methylation and histone modifications, in maintaining viral latency.
• Studies on chromosomal integration and T-cell repertoire analysis to understand the clonal nature of MD lymphomas.

Main Results:

• The basic leucine zipper protein Meq is a critical viral determinant of oncogenicity.
• Noncoding viral sequences, such as viral telomerase RNA and microRNAs, significantly influence MDV oncogenesis.
• Studies indicate that reticuloendotheliosis virus-transformed cell lines can support MDV latency.

Conclusions:

• Significant gaps remain in understanding Marek's disease virus (MDV) latency and pathogenesis.
• Epigenetic regulation plays a role in maintaining viral latency.
• Viral genes, particularly Meq, and noncoding sequences are crucial for MDV-induced oncogenesis.